Understanding and Applying USP 788 Best Practices

USP 788 places limits on the amount of subvisible particles allowed in injections. The USP limits on particulate matter, harmonized with the European Pharmacopoeia (EP) and Japanese Pharmacopoeia (JP) is outlined in USP 788 “Particulate Matter in Injections.”
In this webinar, you can learn how the pharmaceutical product is tested for subvisible particles and how Liquid Particle Counters are validated using reference particles to prove the accuracy of testing.